| 英文别名： |
EVODIAMINE;Evodiamine std.;8,13,13b,14-Tetrahydro-14-methylindolo[2'3'-3,4]pyrido[2,1-b]quinazolin-5-[7H]-one;8,13,13b,14-tetrahydro-14-methyl-,(S)-;Indolo[2',3':3,4]pyrido[2,1-b]quinazolin-5(7H)-one;Indol(2',3':3,4)pyrido(2,1-b)quinazolin-5(7H)-one, 8,13,13b,14-tetrahydro-14-methyl-, (S)-;Indolo(2',3':3,4)pyrido(2,1-b)quinazolin-5(7H)-one, 8,13,13b,14-tetrahydro-14-methyl-;Evodia rutaecarpa E.P.;[13bS,(+)]-8,13,13b,14-Tetrahydro-14-methylindolo[2',3':3,4]pyrido[2,1-b]quinazolin-5(7H)-one;[13bS,(+)]-8,13,13b,14-Tetrahydro-14-methylindolo[2',3':3,4]pyrido[2,1-b]quinazoline-5(7H)-one;d-Evodiamine;(+)-Evodiamine;EVODIAMINE(P) PrintBack;Indolo[2',3':3,4]pyrido[2,1-b]quinazolin-5(7H)-one, 8,13,13b,14-tetrahydro-14-methyl-, (13bS)-;EVODIAMINE PLANT EXTRACT;[
"(+)-Evodiamine"
];Evodiamine;SMR001934404;(S)-14-methyl-7,8,13b,14-tetrahydroindolo[2',3':3,4]pyrido[2,1-b]quinazolin-5(13H)-one;Evodiamine, European Pharmacopoeia (EP) Reference Standard;INDOLO(2',3':3,4)PYRIDO(2,1-B)QUINAZOLIN-5(7H)-ONE, 8,13,13B,14-TETRAHYDRO-14-METHYL-, (13BS)-;BCP02282;CS-6161;C19H17N3O;VS-12304;C09187;CHEMBL463165;(1S)-21-METHYL-3,13,21-TRIAZAPENTACYCLO[11.8.0.0(2),(1)?.0?,?.0(1)?,(2)?]HENICOSA-2(10),4,6,8,15,17,19-HEPTAEN-14-ONE;C01825BVNL;BDBM50560847;(1S)-21-methyl-3,13,21-triazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-2(10),4,6,8,15,17,19-heptaen-14-one;AKOS005622478;MLS006011787;SCHEMBL682158;CHEBI:4948;Q27894193;HY-N0114;(S)-14-methyl-8,13,13b,14-tetrahydroindolo[2',3':3,4]pyrido[2,1-b]quinazolin-5(7H)-one;EVODIAMINE [WHO-DD];Indol(2',3':3,4)pyrido(2,1-b)quinazolin-5(7H)-one, 8,13,13b,14-tetrahydro-14-methyl-, (13bS)-;DTXSID10966123;Evodiamine,(S);EVODIAMINE [MI];Q-100579;Evodiamine, (+)-;UNII-C01825BVNL;518-17-2 |
沪公网安备 
